Cost‐effectiveness analysis of vaginal misoprostol versus dinoprostone pessary: A non‐inferiority large randomized controlled trial in France

Corresponding Author

The Health Economic Unit of the University Hospital of Toulouse, Toulouse, France

UMR1295 CERPOP, Team EQUITY, Toulouse III University, Toulouse, France

University of Toulouse III, Toulouse, France

Correspondence

Michael Mounié, University Hospital of Toulouse, 2 rue Viguerie - TSA 80035, 31059, Toulouse, France.

View original article

0 0 0 0 0 0 0

留言 (0)